Developer docs
API playgroundTry for free, no card

Search company profiles

Deltex Medical Group

Full company profile

uuid003w5h3

Namestring
Deltex Medical Group
Legal namestring
Deltex Medical Group plc
Websiteurl
deltexmedical.com
Company typeenum
Public
Founded yearint
2000
Descriptiontext

Deltex Medical Group plc is a UK-based publicly listed medical device company (LSE: DEMG) founded in 2000 and headquartered in Chichester, England, with 51-100 employees. The company develops and commercializes hemodynamic monitoring technology that measures and analyzes blood flow and cardiovascular parameters in real time, targeting surgical and critical care clinical settings. Its portfolio is built around a core hemodynamic monitoring platform used by hospitals, surgical centers, and critical care units to optimize patient circulatory management during procedures and in intensive care.

The company's revenue model is not publicly disclosed in terms of pricing or unit economics; as a medical device vendor its income is generated through sales of monitoring hardware and associated consumables into healthcare procurement channels, primarily serving hospitals and surgical centers (its primary customer segments). The product's stated differentiator is accuracy and precision in hemodynamic measurement, and the company competes on domain specialization in surgical and critical care monitoring. Prior portfolio expansion includes the 2006 acquisition of Medicina's TECO.

Operationally, the company has faced financial pressure: in July 2023 it conditionally raised approximately GBP 1.7 million via a share placing and subscription (with up to an additional GBP 500,000 via retail offer to existing shareholders), with proceeds earmarked for working capital, restructuring costs, creditor payments, and strategic updates. Leadership includes founder Pauline Thomas, Chairman Edwin Snape, and a combined COO/Chief Scientific Officer role held by Graham Lowe.

Short descriptiontext

Deltex Medical Group plc is a UK-listed medical device company that develops and sells proprietary hemodynamic monitoring technology for real-time blood flow and cardiovascular measurement in surgical and critical care settings, serving hospitals, surgical centers, and critical care units.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersChichester, United Kingdom
HQ citystring
Chichester
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
hemodynamic monitoring, medical device manufacturing, surgical patient monitoring, critical care monitoring, cardiovascular diagnostics
Industry2 codes
1Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
CodeHLAHAFAIPrimaryYes
2Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
CodeHLACAPABPrimaryNo
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Hemodynamic Monitoring Medical Devices
Social media profiles1 record
Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Deltex Medical Group plc develops and sells hemodynamic monitoring medical device technology used in surgical and critical care applications. Its core product is a hemodynamic monitoring platform that enables real-time measurement and analysis of blood flow and cardiovascular parameters to help clinicians assess and manage patients' circulatory status during surgery and in intensive care.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Deltex Medical Group offers a hemodynamic monitoring technology platform designed for surgical and critical care medical applications. The company's core product is its hemodynamic monitoring technology, which enables real-time measurement and analysis of blood flow and cardiovascular parameters during medical procedures. The portfolio consists of specialized monitoring devices and associated technology for surgical and intensive care settings.

Product and service1 record
1Hemodynamic Monitoring Technology
CategoryHemodynamic Monitoring Medical Devices
Description

Medical device technology for hemodynamic monitoring used in surgical and critical care applications to measure and analyze blood flow and cardiovascular parameters. Targeted at hospitals, surgical centers, and critical care units needing real-time circulatory status information to improve patient outcomes.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Market position
Competitive moat3 records

Each record includes

Type, Details

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Deltex Medical Group

Hemodynamic Monitoring Medical Devicesdeltexmedical.com

Deltex Medical Group plc is a UK-listed medical device company that develops and sells proprietary hemodynamic monitoring technology for real-time blood flow and cardiovascular measurement in surgical and critical care settings, serving hospitals, surgical centers, and critical care units.

What Deltex Medical Group does

Deltex Medical Group plc is a UK-based publicly listed medical device company (LSE: DEMG) founded in 2000 and headquartered in Chichester, England, with 51-100 employees. The company develops and commercializes hemodynamic monitoring technology that measures and analyzes blood flow and cardiovascular parameters in real time, targeting surgical and critical care clinical settings. Its portfolio is built around a core hemodynamic monitoring platform used by hospitals, surgical centers, and critical care units to optimize patient circulatory management during procedures and in intensive care.

The company's revenue model is not publicly disclosed in terms of pricing or unit economics; as a medical device vendor its income is generated through sales of monitoring hardware and associated consumables into healthcare procurement channels, primarily serving hospitals and surgical centers (its primary customer segments). The product's stated differentiator is accuracy and precision in hemodynamic measurement, and the company competes on domain specialization in surgical and critical care monitoring. Prior portfolio expansion includes the 2006 acquisition of Medicina's TECO.

Operationally, the company has faced financial pressure: in July 2023 it conditionally raised approximately GBP 1.7 million via a share placing and subscription (with up to an additional GBP 500,000 via retail offer to existing shareholders), with proceeds earmarked for working capital, restructuring costs, creditor payments, and strategic updates. Leadership includes founder Pauline Thomas, Chairman Edwin Snape, and a combined COO/Chief Scientific Officer role held by Graham Lowe.

Deltex Medical Group firmographics

Firmographics
Name
Deltex Medical Group
Legal name
Deltex Medical Group plc
Website
https://deltexmedical.com
Company type
Public
Founded year
2000
Operating status
Operating
Headcount range
51–100 employees
Short description
Deltex Medical Group plc is a UK-listed medical device company that develops and sells proprietary hemodynamic monitoring technology for real-time blood flow and cardiovascular measurement in surgical and critical care settings, serving hospitals, surgical centers, and critical care units.
Ownership category
akta.pro rank

Deltex Medical Group industry classification

Industry
Product category
Hemodynamic Monitoring Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)
akta.pro secondary industry
Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

Keywords

  • Hemodynamic monitoring
  • Medical device manufacturing
  • Surgical patient monitoring
  • Critical care monitoring
  • Cardiovascular diagnostics

Where Deltex Medical Group is headquartered

Location

Headquarters

HQ city
Chichester
HQ country
United Kingdom
HQ region
Europe

Markets served

Deltex Medical Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Deltex Medical Group product offering

Product offering

Core offering

Deltex Medical Group plc develops and sells hemodynamic monitoring medical device technology used in surgical and critical care applications. Its core product is a hemodynamic monitoring platform that enables real-time measurement and analysis of blood flow and cardiovascular parameters to help clinicians assess and manage patients' circulatory status during surgery and in intensive care.

Product overview

Deltex Medical Group offers a hemodynamic monitoring technology platform designed for surgical and critical care medical applications. The company's core product is its hemodynamic monitoring technology, which enables real-time measurement and analysis of blood flow and cardiovascular parameters during medical procedures. The portfolio consists of specialized monitoring devices and associated technology for surgical and intensive care settings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Hemodynamic Monitoring Technology Medical device technology for hemodynamic monitoring used in surgical and critical care applications to measure and analyze blood flow and cardiovascular parameters. Targeted at hospitals, surgical centers, and critical care units needing real-time circulatory status information to improve patient outcomes.

Companies that use Deltex Medical Group

Customer profile

Segments2 records

Ideal customer profiles1 record

Deltex Medical Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Deltex Medical Group partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Deltex Medical Group competitors and assessment

Company assessment

Market position

Competitive moat3 records

Key highlights5 records

Customer concentration

Deltex Medical Group social profiles

Digital presence

Deltex Medical Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Deltex Medical Group leadership team

Management profile

Number of profiles

Profiles3 records

Deltex Medical Group funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Deltex Medical Group M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Deltex Medical Group

What does Deltex Medical Group do?

Deltex Medical Group plc develops and sells hemodynamic monitoring medical device technology used in surgical and critical care applications. Its core product is a hemodynamic monitoring platform that enables real-time measurement and analysis of blood flow and cardiovascular parameters to help clinicians assess and manage patients' circulatory status during surgery and in intensive care.

Is Deltex Medical Group a public or private company?

Deltex Medical Group is a public company. It is classified as public and is currently operating.

When was Deltex Medical Group founded?

Deltex Medical Group was founded in 2000. It employs 51 to 100 people.

Where is Deltex Medical Group based?

Deltex Medical Group is headquartered in Chichester, United Kingdom, in the Europe region.

Does Deltex Medical Group have an API?

No public API is recorded for Deltex Medical Group.

What industry is Deltex Medical Group in?

Deltex Medical Group's product category is Hemodynamic Monitoring Medical Devices. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
LseIN BRIEF: Deltex completes GBP1.7m fundraise, starts retail offerDeltex Medical Group PLC has conditionally raised approximately GBP1.7 million through the placement of 833 million shares at 0.20 pence each to fund working capital and restructuring efforts. The company intends to raise an additional GBP500,000 via a retail offer to existing shareholders, which is scheduled to close on July 19.Morningstar Financial ResearchIN BRIEF: Deltex completes GBP1.7m fundraise, starts retail offerDeltex Medical Group PLC has conditionally raised about GBP1.7 million through a subscription to 833.0 million shares at an issue price of 0.20 pence each. The funds will be used for working capital, internal restructuring costs, creditor payments, and to implement its updated strategy. Additionally, Deltex plans to raise up to GBP500,000 via a retail offer to current shareholders.MarketScreenerDeltex completes GBP1.7m fundraise, starts retail offerDeltex Medical Group plc has completed a GBP1.7m fundraise and initiated a retail offer for its shares. The company is a UK-based developer of hemodynamic monitoring technologies, including the TrueVue platform used in critical care settings.PR NewswireThe hemodynamic monitoring systems market is projected to grow at a CAGR of 6.4%The global hemodynamic monitoring systems market is projected to grow from USD 857.8 million in 2018 to USD 1,167.4 million by 2023 at a CAGR of 6.4%, driven by technological advancements, rising cardiovascular disease prevalence, and increasing government focus on critical care infrastructure, though risks associated with invasive monitoring may restrain growth to some extent. The Asia Pacific region is expected to witness the highest growth during the forecast period, with Japan, India, China, Australia, and Singapore identified as key emerging markets. Key players in the market include Edwards Lifesciences Corporation, PULSION Medical Systems SE, LiDCO Group plc, Cheetah Medical, Deltex Medical Group Plc., ICU Medical, Osypka Medical GmbH, CareTaker Medical, CNSystems, NI Medical, and Uscom.